Allogeneic stem cell transplantation (alloSCT) is a curative treatment for a variety of hematologic diseases. The mechanism of curation by an alloSCT is the induction of an immune response of donor... Show moreAllogeneic stem cell transplantation (alloSCT) is a curative treatment for a variety of hematologic diseases. The mechanism of curation by an alloSCT is the induction of an immune response of donor T cells attacking patients hematopoiesis, including the malignant hematopoietic cells. This is called the graft-versus-leukemia (GVL) reactivity. However, donor T cells can also be directed against healthy tissue cells of the recipient, causing graft-versus-host disease (GVHD). In this thesis we focused on targeting HLA class II by donor CD4 T cells to induce GVL without GVHD, because under non-inflammatory conditions, HLA class II is mainly expressed on hematopoietic cells and not on other tissue cells. We showed that CD4 T cells from HLA-identical sibling donors can induce conversion from mixed to full donor chimerism with GVL reactivity, but without GVHD, by targeting HLA class II restricted minor histocompatibility antigens. We also analyzed the immunopeptidome of different HLA-DP alleles. HLA-DP peptide binding motifs showed a clear association with the HLA-DP allele specific sequences of the binding groove. Functional hierarchies among HLA-DP alleles were unravelled, providing new molecular insights into HLA-DP classification. Permissiveness of mismatches between donor and recipient is not a black and white phenomenon, but rather gradual based on similarities and differences in the peptidomes. Show less
Kampstra, A.S.B.; Heemst, J. van; Janssen, G.M.; Ru, A.H. de; Lummel, M. van; Veelen, P.A. van; Toes, R.E.M. 2019
Human CD4+ T lymphocytes play an important role in inducing potent immune responses. T cells are activated and stimulated by peptides presented in human leucocyte antigen (HLA)-class II molecules.... Show moreHuman CD4+ T lymphocytes play an important role in inducing potent immune responses. T cells are activated and stimulated by peptides presented in human leucocyte antigen (HLA)-class II molecules. These HLA-class II molecules typically present peptides of between 12 and 20 amino acids in length. The region that interacts with the HLA molecule, designated as the peptide-binding core, is highly conserved in the residues which anchor the peptide to the molecule. In addition, as these peptides are the product of proteolytic cleavages, certain conserved residues may be expected at the N- and C-termini outside the binding core. To study whether similar conserved residues are present in different cell types, potentially harbouring different proteolytic enzymes, the ligandomes of HLA-DRB1*03:01/HLA-DRB>1 derived from two different cell types (dendritic cells and EBV-transformed B cells) were identified with mass spectrometry and the binding core and N- and C-terminal residues of a total of 16,568 peptides were analysed using the frequencies of the amino acids in the human proteome. Similar binding motifs were found as well as comparable conservations in the N- and C-terminal residues. Furthermore, the terminal conservations of these ligandomes were compared to the N- and C-terminal conservations of the ligandome acquired from dendritic cells homozygous for HLA-DRB1*04:01. Again, comparable conservations were evident with only minor differences. Taken together, these data show that there are conservations in the terminal residues of peptides, presumably the result of the activity of proteases involved in antigen processing. Show less